Indaptus Therapeutics logo
Indaptus Therapeutics
INDP | NASDAQ
Chart Builder DCF Calculator
$3.45
+$0.28 (+8.83%)
At close: Nov 16, 2026, 4:00 PM ET
$3.45
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:34 PM ET

Indaptus Therapeutics Company Profile

Company profile explained

Company Profile

Indaptus Therapeutics, Inc. is a biotechnology company operating in the pre-clinical phase, dedicated to developing a range of immunotherapeutic products for the treatment of both cancer and viral infections. The firm's lead investigational compound, Decoy20, is currently progressing through Phase I clinical trials. This candidate is being evaluated for its capacity to elicit lasting therapeutic responses, either as a standalone agent or in combination with other treatments, for various conditions including lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as infections caused by the hepatitis B virus and human immunodeficiency virus. Initially incorporated in 2021 under the name Intec Parent, Inc., the company officially rebranded to Indaptus Therapeutics, Inc. in August of the same year. Its corporate headquarters are situated in New York, New York.

Key Executives

Name Position
Junyi Dai CEO & Chairman
Yu Ding Chief Financial Officer

Latest SEC Filings

Date Type Title
Oct 22, 2026 SC 13D/A [Amend] Filing
Oct 22, 2026 SC 13D/A [Amend] Filing
Oct 22, 2026 SC 13D/A [Amend] Filing
Oct 21, 2026 SC 13D/A [Amend] Filing
Oct 20, 2026 8-K Current Report
Oct 05, 2026 S-8 Filing
Sep 30, 2026 8-K Current Report
Sep 10, 2026 8-K Current Report
Sep 08, 2026 8-K/A [Amend] Current Report
Sep 04, 2026 8-K Current Report
View All SEC Filings ➞
Indaptus Therapeutics
Indaptus Therapeutics logo
Country United States
IPO Date Aug 4, 2015
Industry Biotechnology
Sector Healthcare
Employees 5
CEO Junyi Dai

Contact Details

3 Columbus Circle New York City, New York 10019 United States

Stock Details

Ticker Symbol INDP
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001857044
CUSIP Number 45339J204
ISIN Number US45339J2042
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.